Company
Headquarters: New York, NY, United States
| Company | Market Cap (USD) |
|---|---|
| Blackstone | $194.86 B |
| BlackRock | $168.35 B |
| KKR & Co. Inc. | $119.35 B |
| Brookfield Corporation | $105.02 B |
| Brookfield Asset Management Ltd. | $86.42 B |
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $1.072 T |
| JPMorgan | $894.99 B |
| Visa | $668.67 B |
| Mastercard | $509.08 B |
| Bank of America | $414.42 B |
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.
DND Technologies, Inc. has the following listings and related stock indices.
Stock: OTC: DNDT
Headquarters:
954 Lexington Avenue
Suite 505
New York, NY 10021
United States
Phone: 800 341 8940